Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Celebrating in Style

August 02, 2019

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe celebrates 30 years in publishing the latest insights, analysis, and developments of the bio/pharma industry.

The CDMO Evolution

August 02, 2019

Pharmaceutical Technology Europe

The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.

Partnering Up for Success

August 02, 2019

Pharmaceutical Technology Europe

To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.

In Safe Hands

August 02, 2019

Pharmaceutical Technology Europe

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.

Designing Phase-Appropriate CMC Analytical Programs

August 01, 2019

A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.

Industrializing Cell and Gene Therapies

August 01, 2019

Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.

HPAPI Capacity Challenges

August 01, 2019

Does the pharmaceutical industry have adequate access to contained equipment, facilities, and infrastructure for the manufacture of highly potent APIs?

Best Practices for Selecting a Service Provider

August 01, 2019

Key considerations when searching for an analytical service provider include workflow, hardware, and regulatory support.

Cambrex Announces Expansion of Scottish Solid-Form Screening Facility

July 30, 2019

Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.

Catalent Biologics Announces Long-Term Strategic Agreement to Develop Zolgensma

July 17, 2019

Catalent Biologics has entered into a long-term strategic agreement to develop and manufacture an AveXis gene therapy treatment for spinal muscular atrophy (SMA), Zolgensma.